The Company
Press Releases
Awards & Grants
Working at Debiopharm
Corporate Responsibility
Drug Development
At a glance
Pipeline
Products
Publications
Leadership Team
Digital Health Investment
At a Glance
Portfolio
Startup funding
Leadership Team
Manufacturing, Research & Development
At a Glance
Technology pipeline
Leadership Team
Awards & Grants
Corporate Responsibility
Careers
Press Releases
Media
Manage cookies
Contact us
Share
Share
Home
Drug development
Publications
Debio 1143 Mode of Action: a B…
Debio 1143 Mode of Action: a Broad Chemo-Radio and Immuno-Therapy Sensitizer
September 24, 2019
